Abstract
INTRODUCTION: Psoriasis is a common, chronic, immune-mediated inflammatory disorder. The disease is associated with several co-morbidities including cardiovascular disease, metabolic syndrome, and psychiatric disorders. It is important to identify and treat these co-morbidities because they have a strongly negative effect on the overall health of patients with psoriasis. Unfortunately, these co-morbidities are often overlooked and/or left untreated. Therefore, the aim of this review is to discuss the mechanisms of how co-morbidities are associated with psoriasis as well as implications for the clinic to be able to recognize such co-morbidities.
AREAS COVERED: This is a review of studies investigating and discussing co-morbidities of psoriasis and screening. Literature was retrieved by searching on the PubMed database using individual and combined search terms related to relevant co-morbidities. Expert commentary: Effective management of psoriasis involves targeting of both psoriasis and co-morbidities.
| Original language | English |
|---|---|
| Journal | Expert Review of Clinical Immunology |
| Volume | 13 |
| Issue number | 1 |
| Pages (from-to) | 27-34 |
| Number of pages | 8 |
| ISSN | 1744-666X |
| DOIs | |
| Publication status | Published - 28 Jul 2016 |
Fingerprint
Dive into the research topics of 'Co-morbidity in psoriasis: mechanisms and implications for treatment'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS